Based on the above literature, several endogenous WNT proteins such as WNT 3a, WNT 7a/7b, WNT1a, and LRP6 activate the WβC signaling, whereas WNT antagonist GSK-3β and DKK1 inhibit the WβC signaling in AD. This evidence concerns the gene LRP6 and Alzheimer disease.